ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 4 filers reported holding ENCOMPASS HEALTH CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,499,385 | +9.3% | 632,808 | +10.2% | 0.19% | +12.0% |
| Q2 2023 | $38,877,118 | +3867.8% | 574,171 | +3070.3% | 0.17% | +3220.0% |
| Q1 2023 | $979,805 | -94.6% | 18,111 | -94.1% | 0.01% | -95.5% |
| Q4 2022 | $18,249,765 | +934.0% | 305,129 | +681.9% | 0.11% | +909.1% |
| Q3 2022 | $1,765,000 | -73.3% | 39,025 | -58.1% | 0.01% | -68.6% |
| Q1 2022 | $6,621,000 | -19.3% | 93,108 | -26.0% | 0.04% | -18.6% |
| Q4 2021 | $8,209,000 | +6.9% | 125,788 | +22.9% | 0.04% | +2.4% |
| Q3 2021 | $7,680,000 | +36.7% | 102,345 | +42.1% | 0.04% | +31.2% |
| Q2 2021 | $5,619,000 | +60.6% | 72,006 | +68.6% | 0.03% | +45.5% |
| Q1 2021 | $3,498,000 | +189.6% | 42,715 | +192.4% | 0.02% | +175.0% |
| Q4 2020 | $1,208,000 | +100.0% | 14,609 | +57.2% | 0.01% | +60.0% |
| Q3 2020 | $604,000 | +40.8% | 9,295 | +34.3% | 0.01% | +25.0% |
| Q2 2020 | $429,000 | +19.2% | 6,921 | +21.9% | 0.00% | -20.0% |
| Q2 2019 | $360,000 | – | 5,678 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |